Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$419,800
+$97,881 QoQ
Shares Held
350
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#3,901
of 4,605 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI & Co INVESTMENT ADVISERS, INC. holds $10,194,826 across 8 Drug Manufacturers - General names. LLY ranks #4 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OGN |
Organon & Co.
|
548,700 | $7,429,398 | |
| 2 | PFE |
Pfizer Inc
|
25,000 | $602,000 | |
| 3 | GRFS |
Grifols SA
|
77,728 | $550,314 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
350 | $419,800 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,700 | $346,950 | |
| 6 | ABBV |
AbbVie Inc.
|
1,350 | $339,714 | |
| 7 | JNJ |
Johnson & Johnson
|
1,000 | $253,970 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,000 | $252,680 |
All Filings in LLY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $419,800 | 350 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $321,919 | 350 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $376,138 | 350 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $305,200 | 400 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||